On the Legal Supervision of Transgenic Animal Bioreactor Pharmacy in China

Xu-xia LIU,Da-li SHEN,Ning GENG
DOI: https://doi.org/10.3969/J.ISSN.1674-1471.2014.04.013
2014-01-01
Abstract:In recent years,it has become a hot spot to produce medicines with transgenic animal bioreactors in the development and utilization of biotechnology .But the potential benefits and risks coexist in the application of transgenic animal biotechnology .There are no special provisions in the present "Pharmaceutical Administration Law of the People's Republic of China"and its implementing regulations , and other related pharmacy management measures.There are obvious loopholes in the legal system .Therefore,it is necessary to establish a comprehensive system including a preclinical trial system , a clinical quality management system , new pharmacy licensing system , pharmaceutical production and market access system ,and post-marketing adverse reaction reporting and recalling system,to legalize the development of transgenic animal bioreacotrs pharmacy .
What problem does this paper attempt to address?